Factors associated with influenza and pneumococcal vaccine uptake among rheumatoid arthritis patients in Denmark invited to participate in a pneumococcal vaccine trial (Immunovax_RA)

References

• Vinogradova Y, Hippisley-Cox J, Coupland C. Identification of new risk factors for pneumonia: population-based case-control study. Br J Gen Pract 2009;59:e329–38.
   PubMed Web of Science ®Google Scholar
• Shea KM, Edelsberg J, Weycker D, Farkouh RA, Strutton DR, Pelton SI. Rates of pneumococcal disease in adults with chronic medical conditions. Open Forum Infect Dis 2014;1:ofu024.
   PubMedGoogle Scholar
• Wotton CJ, Goldacre MJ. Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses. J Epidemiol Community Health 2012;66:1177–81.
   PubMed Web of Science ®Google Scholar
• Blumentals WA, Arreglado A, Napalkov P, Toovey S. Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study. BMC Musculoskelet Disord 2012;13:158.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481–94.
   PubMed Web of Science ®Google Scholar
• Naz SM, Symmons DP. Mortality in established rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007;21:871–83.
   PubMed Web of Science ®Google Scholar
• Zink A, Manger B, Kaufmann J, Eisterhues C, Krause A, Listing J, et al. Evaluation of the RABBIT risk score for serious infections. Ann Rheum Dis 2014;73:1673–6.
   PubMed Web of Science ®Google Scholar
• Avery RK. Vaccination of the immunosuppressed adult patient with rheumatologic disease. Rheum Dis Clin North Am 1999;25:567–84.
   PubMed Web of Science ®Google Scholar
• Rahier JF, Moutschen M, Van Gompel A, Van Ranst M, Louis E, Segaert S, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) 2010;49:1815–27.
   PubMed Web of Science ®Google Scholar
• Hak E. clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions. Arch Intern Med 2005;165:274.
   PubMedGoogle Scholar
• Beck CR, McKenzie BC, Hashim AB, Harris RC, Nguyen-Van-Tam JS. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology. J Infect Dis 2012;206:1250–9.
   PubMed Web of Science ®Google Scholar
• French N, Gordon SB, Mwalukomo T, White SA, Mwafulirwa G, Longwe H, et al. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults. N Engl J Med 2010;362:812–22.
   PubMed Web of Science ®Google Scholar
• Mori S, Ueki Y, Akeda Y, Hirakata N, Oribe M, Shiohira Y, et al. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tocilizumab therapy. Ann Rheum Dis 2013;72:1362–6.
   PubMed Web of Science ®Google Scholar
• Kaine JL, Kivitz AJ, Birbara C, Luo AY. Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab. J Rheumatol 2007;34:272–9.
   PubMed Web of Science ®Google Scholar
• Hua C, Barnetche T, Combe B, Morel J. Effect of methotrexate, anti-tumor necrosis factor α, and rituximab on the immune response to influenza and pneumococcal vaccines in patients with rheumatoid arthritis: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) 2014;66:1016–26.
   PubMed Web of Science ®Google Scholar
• Fischer L, Gerstel PF, Poncet A, Siegrist CA, Laffitte E, Gabay C, et al. Pneumococcal polysaccharide vaccination in adults undergoing immunosuppressive treatment for inflammatory diseases – a longitudinal study. Arthritis Res Ther 2015;17:151.
   PubMed Web of Science ®Google Scholar
• van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011;70:414–22.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC).Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2012;61:816–9.
   PubMedGoogle Scholar
• Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;2012:625–39.
   Web of Science ®Google Scholar
• Statens Serum Institut. Suggestions for pneumococcal vaccination outside the Childhood Vaccination Programme (http://www.ssi.dk/English/News/EPI-NEWS/2014/No%2040%20-%202014.aspx). Accessed 12 October 2016.
   Google Scholar
• Statens Serum Institut. Pneumocccal vaccination of risk groups outside the Childhood Vaccination Programme in Denmark (http://ssi.dedicated.cohaesio.net/~/media/Indhold/DK%20-%20dansk/Vaccination/Risikogrupper/Pneumokokvaccination%20uden%20for%20brnevaccinationsprogrammet%20i%20Danmark%20v13.ashx). Accessed 12 October 2016.
   Google Scholar
• Loubet P, Kerneis S, Groh M, Loulergue P, Blanche P, Verger P, et al. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency. Vaccine 2015;33:3703–8.
   PubMed Web of Science ®Google Scholar
• Schneeberg A, Bettinger JA, McNeil S, Ward BJ, Dionne M, Cooper C, et al. Knowledge, attitudes, beliefs and behaviours of older adults about pneumococcal immunization, a Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) investigation. BMC Public Health 2014;14:442.
   PubMed Web of Science ®Google Scholar
• Laurence A, Lewis P, Gately C, Dixon A. Influenza and pneumococcal vaccination: do older people know if they have been vaccinated? Aust N Z J Public Health 2016;40:279–80.
   PubMed Web of Science ®Google Scholar
• Lanternier F, Henegar C, Mouthon L, Blanche P, Guillevin L, Launay O. Low influenza-vaccination rate among adults receiving immunosuppressive therapy for systemic inflammatory disease. Ann Rheum Dis 2008;67:1047.
   PubMed Web of Science ®Google Scholar
• Brocq O, Acquacalda E, Berthier F, Albert C, Bolla G, Millasseau E, et al. Influenza and pneumococcal vaccine coverage in 584 patients taking biological therapy for chronic inflammatory joint: a retrospective study. Joint Bone Spine 2016;83:155–9.
   PubMed Web of Science ®Google Scholar
• Costello R, Winthrop KL, Pye SR, Brown B, Dixon WG. Influenza and pneumococcal vaccination uptake in patients with rheumatoid arthritis treated with immunosuppressive therapy in the UK: a retrospective cohort study using data from the clinical practice research datalink. PLoS One 2016;11:e0153848.
   PubMed Web of Science ®Google Scholar
• Cordonnier C, Ljungman P, Juergens C, Maertens J, Selleslag D, Sundaraiyer V, et al. Immunogenicity, safety, and tolerability of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in recipients of allogeneic hematopoietic stem cell transplant aged ≥2 years: an open-label study. Clin Infect Dis 2015;61:313–23.
   PubMed Web of Science ®Google Scholar
• Glesby MJ, Watson W, Brinson C, Greenberg RN, Lalezari JP, Skiest D, et al. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in HIV-infected adults previously vaccinated with pneumococcal polysaccharide vaccine. J Infect Dis 2015;212:18–27.
   PubMed Web of Science ®Google Scholar
• Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, et al. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Arthritis Rheum 2010;62:64–74.
   PubMed Web of Science ®Google Scholar
• Lanternier F, Henegar C, Mouthon L, Blanche P, Christophorov B, Cohen P, et al. Factors influencing influenza-vaccination in adults under immunosuppressive therapy for a systemic inflammatory disease. Med Mal Infect 2009;39:247–51.
   PubMed Web of Science ®Google Scholar
• Doe S, Pathare S, Kelly CA, Heycock CR, Binding J, Hamilton J. Uptake of influenza vaccination in patients on immunosuppressant agents for rheumatological diseases: a follow-up audit of the influence of secondary care. Rheumatology (Oxford) 2006;46:715–16.
   Web of Science ®Google Scholar
• Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81.
   PubMed Web of Science ®Google Scholar
• Kirkwood B, Sterne J, editors. Essential medical statistics, 2nd edn. Oxford: Blackwell Science, 2006:138–47.
   Google Scholar
• DANBIO: Danish Rheumatology Database (https://danbio-online.dk/). Accessed 13 October 2016.
   Google Scholar
• Singh JA, Cameron C, Noorbaloochi S, Cullis T, Tucker M, Christensen R, et al. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet 2015;386:258–65.
   PubMed Web of Science ®Google Scholar
• Danish Health Authority. The use and adverse effects of immunomodulating biological drugs in Denmark (http://sundhedsstyrelsen.dk/~/media/63B8470BBE2A472596C09FCE09AB19DB.ashx). Accessed 1 December 2015.
   Google Scholar
• Hmamouchi I, Winthrop K, Launay O, Dougados M. Low rate of influenza and pneumococcal vaccine coverage in rheumatoid arthritis: data from the international COMORA cohort. Vaccine 2015;33:1446–52.
   PubMed Web of Science ®Google Scholar
• Hua C, Morel J, Ardouin E, Ricard E, Foret J, Mathieu S, et al. Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford) 2015;54:748–50.
   PubMed Web of Science ®Google Scholar
• Michel M, Vincent FB, Rio S, Leon N, Marcelli C. Influenza vaccination status in rheumatoid arthritis and spondyloarthritis patients receiving biologic DMARDs. Joint Bone Spine 2016;83:237–8.
   PubMed Web of Science ®Google Scholar
• Statens Serum Institut. Suggestions for pneumococcal vaccination outside the Childhood Vaccination Programme. 2014 (http://www.ssi.dk/English/News/News/2014/2014%20-%2010%20-%20EPI-NEWS%2040%20pneumococcal.aspx). Accessed 12 October 2016.
   Google Scholar
• Danish Health Authority. Influenza vaccination campaign 2015. Campaign evaluation (https://sundhedsstyrelsen.dk/da/kampagner/~/media/E33478113AF5463CAC7BBDD7125519A7.ashx). Accessed 12 October 2016.
   Google Scholar
• Lawson EF, Trupin L, Yelin EH, Yazdany J. Reasons for failure to receive pneumococcal and influenza vaccinations among immunosuppressed patients with systemic lupus erythematosus. Semin Arthritis Rheum 2015;44:666–71.
   PubMed Web of Science ®Google Scholar
• Assala M, Groh M, Blanche P, Vinter C, Cohen P, Le Cuern V, et al. Pneumococcal and influenza vaccination rates in patients treated with corticosteroids and/or immunosuppressive therapies for systemic autoimmune diseases: a cross-sectional study. Joint Bone Spine 2017;84:356–6.
   Web of Science ®Google Scholar
• Bonten MJ, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med 2015;372:1114–25.
   PubMed Web of Science ®Google Scholar
• Visser LG. TNF-α antagonists and immunization. Curr Infect Dis Rep 2011;13:243–7.
   PubMedGoogle Scholar
• Jackson LA, Gurtman A, van Cleeff M, Frenck RW, Treanor J, Jansen KU, et al. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Vaccine 2013;31:3594–602.
   PubMed Web of Science ®Google Scholar
• Kapetanovic MC, Roseman C, Jonsson G, Truedsson L. Heptavalent pneumococcal conjugate vaccine elicits similar antibody response as standard 23-valent polysaccharide vaccine in adult patients with RA treated with immunomodulating drugs. Clin Rheumatol 2011;30:1555–61.
   PubMed Web of Science ®Google Scholar
• Feikin DR, Elie CM, Goetz MB, Lennox JL, Carlone GM, Romero-Steiner S, et al. Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults. Vaccine 2001;20:545–53.
   PubMed Web of Science ®Google Scholar
• Greenberg RN, Gurtman A, Frenck RW, Strout C, Jansen KU, Trammel J, et al. Sequential administration of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in pneumococcal vaccine-naive adults 60–64 years of age. Vaccine 2014;32:2364–74.
   PubMed Web of Science ®Google Scholar
• Kobie JJ, Zheng B, Bryk P, Barnes M, Ritchlin CT, Tabechian DA, et al. Decreased influenza-specific B cell responses in rheumatoid arthritis patients treated with anti-tumor necrosis factor. Arthritis Res Ther 2011;13:R209.
   PubMed Web of Science ®Google Scholar
• Franca IL, Ribeiro AC, Aikawa NE, Saad CG, Moraes JC, Goldstein-Schainberg C, et al. TNF blockers show distinct patterns of immune response to the pandemic influenza A H1N1 vaccine in inflammatory arthritis patients. Rheumatology (Oxford) 2012;51:2091–8.
   PubMed Web of Science ®Google Scholar
• Kapetanovic MC, Saxne T, Nilsson JA, Geborek P. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology (Oxford) 2007;46:608–11.
   PubMed Web of Science ®Google Scholar
• Gelinck LB, van der Bijl AE, Visser LG, Huizinga TW, van Hogezand RA, Rijkers GT, et al. Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine. Vaccine 2008;26:3528–33.
   PubMed Web of Science ®Google Scholar
• Kapetanovic MC, Saxne T, Sjoholm A, Truedsson L, Jonsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology (Oxford) 2006;45:106–11.
   PubMed Web of Science ®Google Scholar
• Jiménez-García R, Hernandez-Barrera V, Rodríguez-Rieiro C, Carrasco Garrido P, López de Andres A, Jimenez-Trujillo I, et al. Comparison of self-report influenza vaccination coverage with data from a population based computerized vaccination registry and factors associated with discordance. Vaccine 2014;32:4386–92.
   PubMed Web of Science ®Google Scholar
• Rolnick SJ, Parker ED, Nordin JD, Hedblom BD, Wei F, Kerby T, et al. Self-report compared to electronic medical record across eight adult vaccines: do results vary by demographic factors? Vaccine 2013;31:3928–35.
   PubMed Web of Science ®Google Scholar